Breaking News Instant updates and real-time market news.

IMAX

Imax

$21.35

0.27 (1.28%)

04:55
08/14/19
08/14
04:55
08/14/19
04:55

Imax management to meet with MKM Partners

Meeting to be held in Boston, MA on August 14 hosted by MKM Partners.

  • 14

    Aug

  • 05

    Sep

  • 05

    Sep

IMAX Imax
$21.35

0.27 (1.28%)

02/25/19
02/25/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Imax (IMAX) downgraded to Hold from Buy Canaccord by analyst Aravinda Galappatthige, who cited weak box office trends, particularly in China. He believes the uncertainty around the China outlook and the less friendly slate of movies for 2019 will also be headwinds. 2. SQM (SQM) downgraded to Hold from Buy at Deutsche Bank by analyst Chris Terry, who said he is moving to the sidelines following the 9% share price increase over the past two weeks. He likes the fundamentals of the business but believes that the first half of the year "could still provide some moderate headwinds." 3. PayPal (PYPL) downgraded to Neutral from Buy at Buckingham. 4. Motif Bio (MTFB) downgraded to Neutral from Buy at H.C. Wainwright by analyst Raghuram Selvaraju, who said he is unsure whether the FDA would ever approve iclaprim, "regardless of what data Motif might be able to furnish." Further, he believes there is "considerable uncertainty regarding Motif's ability to fund such studies." 5. Allegion (ALLE) downgraded to In-Line from Outperform at Imperial Capital by analyst Jeff Kessler, who sees 7% potential upside following the company's Q4 results and 2019 results. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/12/19
MKMP
04/12/19
NO CHANGE
Target $28
MKMP
Buy
Imax price target raised to $28 from $27 at MKM Partners
MKM Partners analyst Eric Handler raised his price target on Imax to $28 and kept his Buy rating, saying the company's "refocused efforts toward its core business" are on track to produce "near double-digit global box office growth, expanded gross margin, and rising free cash flow generation" in 2019. The analyst also raises his FY19 EPS view by 2c to $1.11 going into the release of "Avengers: Endgame" title later this month and the start of the summer season.
04/30/19
BRRR
04/30/19
NO CHANGE
BRRR
Barrington says 'Endgame' highlights blockbuster strategy opportunity for IMAX
Barrington analyst James Goss reaffirmed an Outperform rating and $27 price target on IMAX following "Avengers: Endgame" having the biggest opening of all time both domestically and in key international markets this past weekend. Goss said the "hit driven element" in Imax's growth due to the company's focus on blockbuster films, and it shows, as management "raised its 2019 IMAX box office guidance to a low-double-digit percentage gain, which contrasts with much more modest expectations for the overall domestic box office, with which IMAX does not totally compare in film mix."
05/31/19
MKMP
05/31/19
NO CHANGE
Target $28
MKMP
Buy
Imax should not be impacted by China trade tensions, says MKM Partners
MKM Partners analyst Eric Handler kept his Buy rating and $28 price target on Imax, saying that while the recent weakness in its stock has been driven by China trade war worries, he believes that the company should not be impacted. The analyst states that he has seen no signs for any tariffs to weigh on the Hollywood film product and also points to IMAX's global box office in China, which is currently "in record territory and outpacing the industry growth rate." Handler adds that the company's Q2 global box office is tracking in line or slightly better than consensus while its back-half film slate also looks "much improved".

TODAY'S FREE FLY STORIES

TELL

Tellurian

$9.04

0.75 (9.05%)

13:25
08/22/19
08/22
13:25
08/22/19
13:25
Options
Tellurian call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:25
08/22/19
08/22
13:25
08/22/19
13:25
General news
Treasury's $7 B 30-year TIPS reopening was well received »

Treasury's $7 B…

13:21
08/22/19
08/22
13:21
08/22/19
13:21
General news
30-Yr TIPS Auction Bid/Cover data reported »

30-Yr TIPS Auction…

13:21
08/22/19
08/22
13:21
08/22/19
13:21
General news
30-Yr TIPS Auction Total Amount data reported »

30-Yr TIPS Auction Total…

NTRA

Natera

$30.66

0.25 (0.82%)

13:18
08/22/19
08/22
13:18
08/22/19
13:18
Hot Stocks
Natera reports 'positive' local coverage determination issued by Palmetto MolDX »

Natera announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
08/22/19
08/22
13:17
08/22/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
08/22/19
08/22
13:16
08/22/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:15
08/22/19
08/22
13:15
08/22/19
13:15
General news
FX Action: USD-JPY »

FX Action: USD-JPY…

NTRA

Natera

$30.53

0.12 (0.39%)

13:13
08/22/19
08/22
13:13
08/22/19
13:13
Recommendations
Natera analyst commentary  »

Piper says Natera gets…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

13:10
08/22/19
08/22
13:10
08/22/19
13:10
General news
FX Action: USD-CAD »

FX Action: USD-CAD peaked…

AMGN

Amgen

$204.16

0.32 (0.16%)

13:06
08/22/19
08/22
13:06
08/22/19
13:06
Hot Stocks
Amgen granted orphan designation for multiple myeloma treatment »

Amgen was granted orphan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 16

    Sep

  • 19

    Sep

ZIOP

Ziopharm

$5.09

-0.06 (-1.17%)

13:05
08/22/19
08/22
13:05
08/22/19
13:05
Options
Ziopharm call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 12

    Sep

SNY

Sanofi

$42.69

-0.48 (-1.11%)

13:04
08/22/19
08/22
13:04
08/22/19
13:04
Hot Stocks
Sanofi treatment of systemic sclerosis granted orphan designation »

Sanofi U.S. Service was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 16

    Sep

  • 23

    Sep

  • 02

    Oct

WFC

Wells Fargo

$45.62

0.63 (1.40%)

13:03
08/22/19
08/22
13:03
08/22/19
13:03
Periodicals
Wells Fargo to pay $6.5M to Navajo Nation to settle account suit, Reuters says »

Wells Fargo intends to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 12

    Oct

  • 15

    Oct

  • 27

    Oct

ILMN

Illumina

$288.00

-2.5 (-0.86%)

13:02
08/22/19
08/22
13:02
08/22/19
13:02
Hot Stocks
Illumina granted orphan designation neuroblastoma management diagnostic »

Illumina…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Sep

OSTK

Overstock.com

$21.84

2.34 (12.00%)

12:49
08/22/19
08/22
12:49
08/22/19
12:49
Hot Stocks
Breaking Hot Stocks news story on Overstock.com »

Overstock.com trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OSTK

Overstock.com

$21.40

1.9 (9.74%)

12:45
08/22/19
08/22
12:45
08/22/19
12:45
Options
Overstock com call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$203.13

-0.71 (-0.35%)

, ALXN

Alexion

$118.04

3.17 (2.76%)

12:43
08/22/19
08/22
12:43
08/22/19
12:43
Recommendations
Amgen, Alexion analyst commentary at Piper Jaffray »

Piper Jaffray says Amgen…

AMGN

Amgen

$203.13

-0.71 (-0.35%)

ALXN

Alexion

$118.04

3.17 (2.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 16

    Sep

  • 19

    Sep

  • 02

    Oct

  • 19

    Oct

12:40
08/22/19
08/22
12:40
08/22/19
12:40
General news
Fed funds futures are lower after the hawkish comments »

Fed funds futures are…

ADM

Archer Daniels

$37.93

0.23 (0.61%)

, REGI

Renewable Energy

$11.27

0.42 (3.87%)

12:38
08/22/19
08/22
12:38
08/22/19
12:38
Periodicals
Trump to discuss biofuels with USDA, EPA officials, Reuters reports »

President Donald Trump is…

ADM

Archer Daniels

$37.93

0.23 (0.61%)

REGI

Renewable Energy

$11.27

0.42 (3.87%)

GPRE

Green Plains

$8.03

0.15 (1.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

OSTK

Overstock.com

$19.54

0.04 (0.21%)

12:33
08/22/19
08/22
12:33
08/22/19
12:33
Hot Stocks
Byrne says Overstock's blockchain keiretsu will revolutionize the world »

In a letter to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OSTK

Overstock.com

$19.54

0.04 (0.21%)

12:30
08/22/19
08/22
12:30
08/22/19
12:30
Hot Stocks
Breaking Hot Stocks news story on Overstock.com »

Overstock com trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$292.12

-0.28 (-0.10%)

, SPX

S&P 500

$0.00

(0.00%)

12:29
08/22/19
08/22
12:29
08/22/19
12:29
General News
Canada still against Russia's return to G8, Reuters says »

Canada's government…

SPY

SPDR S&P 500 ETF Trust

$292.12

-0.28 (-0.10%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$292.07

-0.335 (-0.11%)

, SPX

S&P 500

$0.00

(0.00%)

12:28
08/22/19
08/22
12:28
08/22/19
12:28
General News
Ukraine, EU rebuff Trump's suggestion of admitting Russia to G7, Reuters says »

Ukraine's President…

SPY

SPDR S&P 500 ETF Trust

$292.07

-0.335 (-0.11%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$181.29

-2.27 (-1.24%)

, SNAP

Snap

$16.24

0.1 (0.62%)

12:27
08/22/19
08/22
12:27
08/22/19
12:27
Periodicals
Gun sellers allegedly used Snapchat to sell illegal guns, Guardian says »

Darwin BondGraham, a…

FB

Facebook

$181.29

-2.27 (-1.24%)

SNAP

Snap

$16.24

0.1 (0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 24

    Sep

  • 27

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.